OPTFSNA
CARM

Old Point Trust & Financial Services N A’s Carisma Therapeutics CARM Stock Holding History

Old Point Trust & Financial Services N A’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-125
Closed -$190 – 319
2024
Q2 		$190 Hold
125
– – ﹤0.01% 332
2024
Q1 		$284 Buy
+125
New +$300 ﹤0.01% 504

Other funds holding CARM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TOTUOP
Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania $297M AUM
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Old Point Trust & Financial Services N A's CARM Position: Q3 2024 in Review

Old Point Trust & Financial Services N A sold out of Carisma Therapeutics (CARM) in Q3 2024, closing a stake of 125 shares — an estimated $190 sold.

Old Point Trust & Financial Services N A first reported a position in CARM in Q1 2024 and held it in 2 quarters. The position peaked at $284 in Q1 2024. 37 funds tracked by Wall St. Rank hold CARM as of Q3 2024.

  • Old Point Trust & Financial Services N A reported no remaining Carisma Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Old Point Trust & Financial Services N A sold 125 Carisma Therapeutics shares in Q3 2024, an estimated $190.
  • Old Point Trust & Financial Services N A first reported a position in Carisma Therapeutics in Q1 2024 and held it in 2 quarters.
  • Old Point Trust & Financial Services N A's Carisma Therapeutics position peaked at $284 in Q1 2024.
  • 37 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q3 2024.

Based on Old Point Trust & Financial Services N A's 13F filing for Q3 2024, filed 8 Nov 2024.